National Health Investors (NYSE:NHI) Sets New 1-Year High – Here’s What Happened

National Health Investors, Inc. (NYSE:NHI)’s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as $90.58 and last traded at $90.41, with a volume of 6531 shares changing hands. The stock had previously closed at $89.31.

Wall Street Analyst Weigh In

Several research firms have recently commented on NHI. Weiss Ratings reissued a “buy (b)” rating on shares of National Health Investors in a research note on Monday, December 29th. KeyCorp boosted their price target on shares of National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a report on Thursday, December 4th. National Bank Financial set a $85.00 price target on shares of National Health Investors in a research note on Tuesday, January 20th. Cantor Fitzgerald set a $85.00 target price on National Health Investors in a research note on Monday, January 5th. Finally, Deutsche Bank Aktiengesellschaft cut National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price objective for the company. in a report on Tuesday, January 20th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $85.57.

National Health Investors Stock Performance

The company has a debt-to-equity ratio of 0.74, a current ratio of 10.64 and a quick ratio of 10.64. The company has a fifty day moving average price of $79.71 and a two-hundred day moving average price of $77.83. The company has a market capitalization of $4.29 billion, a P/E ratio of 28.44, a PEG ratio of 3.05 and a beta of 0.66.

Institutional Trading of National Health Investors

Several institutional investors have recently made changes to their positions in NHI. NewEdge Advisors LLC lifted its stake in National Health Investors by 28.7% in the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after purchasing an additional 345 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of National Health Investors by 9.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock valued at $18,460,000 after acquiring an additional 21,851 shares during the last quarter. Jane Street Group LLC grew its stake in National Health Investors by 1,728.4% in the 1st quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock worth $5,148,000 after buying an additional 65,885 shares in the last quarter. Allianz Asset Management GmbH increased its stake in National Health Investors by 111.9% in the second quarter. Allianz Asset Management GmbH now owns 120,625 shares of the real estate investment trust’s stock valued at $8,458,000 after acquiring an additional 63,697 shares during the last quarter. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of National Health Investors during the 2nd quarter valued at about $3,871,000. Institutional investors own 62.51% of the company’s stock.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.